Incidental papillary microcarcinoma of the thyroid - Further evidence of a very low malignant potential: A retrospective clinicopathological study with up to 30 years of follow-up

Annals of Surgical Oncology

Volumn 18, Issue 12, 2011, Pages 3430-3436

  Neuhold, Nikolaus ^a   Schultheis, Andrea ^a   Hermann, Michael ^b   Krotla, Gabriela ^b   Koperek, Oskar ^b   Birner, Peter ^b  

^a Kaiserin Elisabeth Spital der Stadt Wien ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; DEMOGRAPHY; EXPERIENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID DISEASE; THYROID PAPILLARY CARCINOMA; THYROID PAPILLARY MICROCARCINOMA; THYROID SURGERY; THYROIDECTOMY;

ADULT; CARCINOMA, PAPILLARY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TIME FACTORS;

EID: 83055184541     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1663-x     Document Type: Article

References (38)

1. Livolsi VA, Saavedra JA. Papillary carcinoma. In: De Lellis RA, Lloyd RV, Heitz PU, Eng C, erance: IARC Press; 2004. p. 57-66.
2. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer. 1975;36:1095-9.
3. Harrach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer. 1985;56:531-8.
4. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid: Evaluation of 1020 sequential autopsies. Am J Clin Pathol. 1988;40:72-6.
5. Martinez-Tello F J, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different Methods. Cancer. 1993;71:4022-9.
6. Neuhold, Kaiser H, Kaserer K. Latent carcinoma of the thyroid in Austria: a systematic autopsy study. Endocrin Pathol. 2001;12:23-31.
7. Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki: prevalence of thyroid carcinoma at autopsy. JAMA. 1969;209:65-70.
8. Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol. 1996;9:816-20.
9. Nikiforov YE. Thyroid tumors: Classification and general considerations. In: Nikiforov YE, Biddinger PW, Thompson LDR, editors. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 95-102.
10. Statistik Austria. Available: http://www.statistik.at/web-de/statistiken/ gesundheit/krebserkrankungen/schilddruese/021796.html. Accessed 22 Aug. 2010.
11. Grodski S, Brown T, Sidhu S, et al. Increased incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008;144:1038-43.
12. Gomez Segovia I, Gallowitsch HJ, Kresnik E, et al. Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid. 2004;14:277-86.
13. Harach HRH. Iodine deficiency and thyroid cancers: effect of iodine prophylaxis on thyroid cancer morphology. In: Preedy VR, Burrow GN, Watson R, editors. Comprehensive handbook of iodine. Oxford: Academic Press; 2009. p. 513-9.
14. Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C. Thyroid cancer in Luxembourg: a national population-based data (1983-1999). BMC Cancer. 2006;6:102.
15. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
16. Mazzaferi EL. Managing small thyroid cancers. JAMA. 2006;295:2179-82.
17. Ito Y, Miyauchi A, Inoue H, et al. An observation trial for papillary thyroid microcarcinoma. World J Surg. 2010;34:28-35.
18. Cappelli C, Castellano M, Braga M, et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol. 2007;95:555-60.
19. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastases and multifocality. Cancer. 2003;98:31-40.
20. Roti E, Rossi R, Trasforini G, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocr Metabol. 2006;91:2171-8.
21. Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer. 1998;83:553-9.
22. Hay ID, Hutchinson ME, Gonzales-Londosa T, et al. Papillary thyroid microcarcinoma: s study of 900 cases observed in a 60-year period. Surgery. 2008;144:908-88.
23. Noguchi S, Yamashita H, Uchino S, Watanabe S. Papillary microcarcinoma. World J Surg. 2008;32:747-53.
24. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer. 1987;60:1767-70.
25. Rosai J, Carcangiu ML, De Lellis RA. Tumors of the thyroid gland. Washington, DC: Armed Forces Institute of Pathology; 1992.
26. Albores Saavedra J, Hendon DE, Glazer E, Schwartz AM. Changing patterns in incidence and survival of thyroid cancer with follicular phenotype-papillary, follicular and anaplastic: a morphological and epidemiological study. Endocr Pathol. 2007;18:1-7.
27. Bansal M, Mantha G, Nikiforov YE. Molecular and histopathological features of multifocal papillary thyroid carcinomas. Mod Pathol. 2010;23:126A-33A.
28. Lin X, Finkelstein SD, Zhu B, Silverman JF. Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol. 2008;41:195-203.
29. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab. 1998;83:4116-22.
30. Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol. 2003;14:183-91.
31. Baloch ZW, Li Volsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006;13:69-75.
32. Gemsenjäger E, Heitz PU, Seifert B, Martina B, Schweizer I. Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years. Swiss Med Wkly. 2001;131:157-63.
33. Appetecchia M, Scarcello G, Pucci E, Procaccini A. Outcome after treatment of papillary thyroid microcarcinoma. J Clin Cancer Res. 2002;21:159-64.
34. Bassam A, Daher R, Sleitlaty G, Abidijan G, Ghorra C. Are papillary microcarcinomas of the thyroid revealed by cervical adenopathy more aggressive? Am Surg. 2010;76:306-11.
35. Qubain SW, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002;131:249-56.
36. Bai Y, Zhou G, Nakamura M, et al. Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol. 2009;22:887-94.
37. Das DK. Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor? Diagn Cytopathol. 2009;37:534-41.
38. Rosai J, Li Volsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003;11:249-51.